uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Macugen
Withdrawn
Human
Details
EMA number
EMEA/H/C/000620
ATC code
S01LA03
Authorisation
31 January 2006
Revision
15
EMA page
Therapeutic indication
Macugen is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD).
MeSH:
Wet Macular Degeneration
Group:
Ophthalmologicals
Active substances
pegaptanib
Marketing Authorisation Holder
PharmaSwiss Ceska Republika s.r.o
MAH
Timeline
Filter by authority:
EMA
Macugen authorised
31 Jan 2006
authorised
regulatory
Macugen | uMedical